Companies · Other Health Care

ForSight VISION5, Inc.

MENLO PARK · Other Health Care

Diligence memoA one-page analyst read on ForSight VISION5, Inc. — recommendation, valuation, rhythm, risks.
$76.8M
Total raised · real
9
Rounds
0.2×
Latest step-up
Top 6%
Sector rank · raised
Series A
Latest stage · inferred · Mon Aug 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

ForSight VISION5, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.97× the median modeled value of Series A Other Health Care companies in 2013–2015 (187 peers) — value vs value, same stage and era.
Dormant
  • Last raise 10.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

ForSight VISION5, Inc. is one of 5377 Other Health Care companies tracked from MENLO PARK. By capital raised it ranks among the largest (ahead of 95% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries A · 2011-01-31 Raised $6.0M (real) Modeled valuation $121M (est)Series A2011Series A · 2012-08-15 Raised $8.0M (real) Modeled valuation $161M (est)Series A2012Series A · 2013-04-05 Raised $9.3M (real) Modeled valuation $188M (est)Series A2013Series A · 2013-04-05 Raised $9.2M (real) Modeled valuation $186M (est)Series A2013Series A · 2013-04-05 Raised $8.0M (real) Modeled valuation $161M (est)Series A2013Series A · 2014-04-15 Raised $15M (real) Modeled valuation $303M (est)Series A2014Series A · 2015-08-24 Raised $12M (real) Modeled valuation $238M (est)Series A2015Series A · 2015-08-24 Raised $7.8M (real) Modeled valuation $157M (est)Series A2015Series A · 2015-08-24 Raised $1.7M (real) Modeled valuation $34M (est)Series A2015+$8.0M+$9.3M+$9.2M+$8.0M+$15M+$12M+$7.8M+$1.7MCumulative $77M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.0M · 2011
Series A extension$8.0M · 2012
Series A extension$9.3M · 2013
Series A extension$9.2M · 2013
Series A extension$8.0M · 2013
Series A extension$15.0M · 2014
Series A extension$11.8M · 2015
Series A extension$7.8M · 2015
Series A extension$1.7M · 2015

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$238.2M
Base estimate est.
$15.1M
Conservative case
$1.3B
Upside case
$53.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $121.1M · 2011-01-312011Series A · modeled $161.4M · 2012-08-15Series A · modeled $187.7M · 2013-04-05Series A · modeled $185.7M · 2013-04-05Series A · modeled $161.5M · 2013-04-05Series A · modeled $302.7M · 2014-04-15Series A · modeled $238.2M · 2015-08-24Series A · modeled $157.4M · 2015-08-24Series A · modeled $34.3M · 2015-08-242015
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
10.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
7 mo
Avg between rounds
$16.8M/yr
Capital velocity
15.4 yr
On record since
2011
First round
9
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 32× above median
This company$76.8M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.3× of median
This company$1.7M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 11× above median
This company$238.2M
Sector median$22.1M

Raised more than 95% of sector peers (real $). Modeled value above 89% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #21 of 187.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Imagine Health, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Spruce Health, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Inova Labs, Inc. · Series A Raised $32.6M · modeled $302.7M (est)Cephea Valve Technologies, Inc. · Series A Raised $21.2M · modeled $296.8M (est)ClarVista Medical, Inc. · Series A Raised $14.5M · modeled $293.0M (est)Minimally Invasive Devices Inc. · Series A Raised $43.3M · modeled $284.9M (est)Osprey Medical Inc. · Series A Raised $14.0M · modeled $282.5M (est)IGeneX Group, LLC · Series A Raised $13.5M · modeled $273.4M (est)Urohsd, Llc · Series A Raised $13.2M · modeled $266.9M (est)Secure EDI Holdings, LLC · Series A Raised $28.3M · modeled $263.5M (est)Sterling Healthcare Holdings, Llc · Series A Raised $13.4M · modeled $259.1M (est)Wallick Senior Housing Holdings, LLC · Series A Raised $12.8M · modeled $259.1M (est)ForSight VISION5, Inc. (this company) Raised $76.8M · modeled $238.2M (est)ForSight VISION5, Inc.
CompanyStageRaised · realValue · estvs peer med.
Imagine Health, Inc.Series A$15.0M$302.7M2.50×
Spruce Health, Inc.Series A$15.0M$302.7M2.50×
Inova Labs, Inc.Series A$32.6M$302.7M2.50×
Cephea Valve Technologies, Inc.Series A$21.2M$296.8M2.46×
ClarVista Medical, Inc.Series A$14.5M$293.0M2.42×
Minimally Invasive Devices Inc.Series A$43.3M$284.9M2.36×
Osprey Medical Inc.Series A$14.0M$282.5M2.34×
IGeneX Group, LLCSeries A$13.5M$273.4M2.26×
Urohsd, LlcSeries A$13.2M$266.9M2.21×
Secure EDI Holdings, LLCSeries A$28.3M$263.5M2.18×
Sterling Healthcare Holdings, LlcSeries A$13.4M$259.1M2.14×
Wallick Senior Housing Holdings, LLCSeries A$12.8M$259.1M2.14×
ForSight VISION5, Inc. this companySeries A$76.8M$238.2M1.97×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.0M2011-01-31$27.3M$121.1M90%
Series A$8.0M2012-08-15$36.4M$161.4M90%
Series A$9.3M2013-04-05$42.3M$187.7M90%
Series A$9.2M2013-04-05$41.8M$185.7M90%
Series A$8.0M2013-04-05$36.4M$161.5M90%
Series A$15.0M2014-04-15$68.2M$302.7M90%
Series A$11.8M2015-08-24$53.6M$238.2M90%
Series A$7.8M2015-08-24$35.5M$157.4M90%
Series A$1.7M2015-08-24$7.7M$34.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.0M2011-01-31
    • First recorded raise — entered as Series A.
  2. Series A$8.0M2012-08-15
    • Raised 18 mo later, in step with the ~14 mo sector norm.
    • Round 1.3× larger than the prior — scaling up.
  3. Series A$9.3M2013-04-05
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  4. Series A$9.2M2013-04-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  5. Series A$8.0M2013-04-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  6. Series A$15.0M2014-04-15
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
  7. Series A$11.8M2015-08-24
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  8. Series A$7.8M2015-08-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
  9. Series A$1.7M2015-08-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.6× smaller than the prior — bridge or down round.
Intelligence
2016 ~Q1
Modeled next raise · ~7mo cadence
$1.7M
Modeled next size est.range $1.7M$2.7M
0.2×
Last step-up
$16.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Hanson S. Gifford III10 other2011-01
K. Angela Macfarlane4 other2011-01
John F. Maroney3 other2014-04
Robert C. Bellas, Jr.3 other2011-01
William J. Link, Ph.D.3 other2011-01
Charles M. Warden2 other2011-01
Aaron S. Davidson1 other2014-04
Andy S. Corley2015-08
Eugene S. De Juan, Jr., M.D.2011-01
Ferolyn J. Powell2012-08
Jim J. Glasheen2013-04
Registry & provenance

ForSight VISION5, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1512390
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
ForSight VISION4, Inc.Other Health CareSeries A$6.0M$121.1Mnetwork5 shared operators · same sector · same stage
Nexis Vision, Inc.Other Health CareSeries A$30.3M$15.1Mnetwork4 shared operators · same sector · same stage
Transcend Medical IncOther Health CareSeries B$122.3M$648.4Mnetwork2 shared operators · same sector
ForSight VISION6, Inc.Other Health CareSeed$7.5M$74.4Mnetwork2 shared operators · same sector
Reprieve Cardiovascular, Inc.Other Health CareSeries B$82.4M$153.0Mnetwork1 shared operator · same sector
Miramar Labs IncOther Health CareSeries B$87.2M$95.9Mnetwork1 shared operator · same sector
Airxpanders IncOther Health CareSeries A$60.0M$300.5Msame sector · same stage
Pivot Medical IncOther Health CareSeries B$43.1M$717.7Mnetwork1 shared operator · same sector
Frequently asked
How much funding has ForSight VISION5, Inc. raised?
ForSight VISION5, Inc. has raised approximately $76.8M in disclosed capital across 9 recorded financing rounds, aggregated from public filings.
What is ForSight VISION5, Inc.'s estimated valuation?
Provath's modeled valuation for ForSight VISION5, Inc. is approximately $238.2M (modeled range $15.1M–$1.3B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is ForSight VISION5, Inc. at?
ForSight VISION5, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Aug 24.
What does ForSight VISION5, Inc. do and where is it based?
ForSight VISION5, Inc. operates in the Other Health Care sector, based in MENLO PARK.
Explore related

See where ForSight VISION5, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at ForSight VISION5, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.